(Q36314825)

13 August 2017

1 reference

title

Isosorbide dinitrate and hydralazine hydrochloride: a review of efficacy and safety (English)

1 reference

13 August 2017

1 reference

1 reference

Keith C Ferdinand

1

1 reference

13 August 2017

publication date

1 November 2005

1 reference

Expert Review of Cardiovascular Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

3

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

993-1001

1 reference

Racial differences in patients with heart failure.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Heart failure in African Americans: pathophysiology and treatment*1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

The benefits of valsartan in the treatment of heart failure: results from Val-HeFT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Ozone--from environmental pollutant to atherogenic determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Redox regulation of cardiomyocyte survival and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Oxygen free radicals and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

The physiology and pathophysiology of the nitric oxide/superoxide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Vasodilation in black Americans: attenuated nitric oxide-mediated responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Effects of black race on forearm resistance vessel function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

Transplacental passage and breast milk concentrations of hydralazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.6.993

21 January 2018

Identifiers

DOI

10.1586/14779072.3.6.993

1 reference

13 August 2017

1 reference